Skip to main content
. 2022 Feb 20;11(4):1121. doi: 10.3390/jcm11041121

Figure 2.

Figure 2

Effects after methylene blue administration in vasoplegic syndrome: The figures show the median (25th–75th percentile) value in the main study group with regard to the use of methylene blue (blue) versus standard therapy (grey). p-value indicates standard mean (SD). (A) Mean Arterial pressure; (B) Cumulative fluid administration; (C) Actual norepinephrine dose; (D) Actual vasopressin dose; (E) Cumulative vasopressoe amount.